(Q35958931)

11 August 2017

1 reference

title

Intravenous immunoglobulins for Alzheimer's disease. (English)

1 reference

11 August 2017

0 references

Howard Fillit

1

1 reference

11 August 2017

publication date

1 December 2004

1 reference

11 August 2017

1 reference

11 August 2017

volume

3

1 reference

11 August 2017

issue

12

1 reference

11 August 2017

page(s)

704

1 reference

Identification of components of immunoglobulins in senile plaques by means of fluorescent antibody technique

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900929-9

7 January 2021

Evidence for the presence of antibodies to cholinergic neurons in the serum of patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900929-9

7 January 2021

Immunotherapeutic Approaches to Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900929-9

7 January 2021

The potential of anti-inflammatory drugs for the treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900929-9

7 January 2021

Intravenous immunoglobulins: a treatment for Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900929-9

7 January 2021

Epitope and isotype specificities of antibodies to beta -amyloid peptide for protection against Alzheimer's disease-like neuropathology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900929-9

7 January 2021

Autoimmunity in Alzheimer's disease: increased levels of circulating IgGs binding Abeta and RAGE peptides

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900929-9

7 January 2021

Novel therapeutic approach for the treatment of Alzheimer's disease by peripheral administration of agents with an affinity to beta-amyloid.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900929-9

7 January 2021

Intravenous immunoglobulins containing antibodies against beta-amyloid for the treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900929-9

7 January 2021

10.1016/S1474-4422(04)00929-9

Identifiers

DOI

1 reference

11 August 2017

1 reference